BR Shetty faces $5.4bn fraud trial over NMC Health collapse, six years on

BR Shetty, who built NMC Health into the UAE's largest private hospital network, faces a $5.4 billion fraud trial over the group's 2020 collapse, which revealed $6.6 billion in hidden debt.

The collapse that reshaped Abu Dhabi's private health sector

NMC Health entered administration in April 2020 after Muddy Waters Research, the US short-seller, published a report in December 2019 questioning the accuracy of the company's financial statements. Auditors discovered hidden borrowings far exceeding what was reported on the balance sheet, with total debts eventually tallied at over $6.6 billion against the $2.1 billion disclosed to shareholders.

At its peak, NMC operated more than 200 facilities across the UAE, including hospitals, clinics, and long-term care units licensed by the Abu Dhabi Department of Health (DOH) and the Dubai Health Authority (DHA). The group employed more than 20,000 staff in the Emirates alone. Its 2012 listing on the London Stock Exchange made it the first UAE company admitted to the FTSE 100.

What the trial will determine

The proceedings, reported by The Times on 23 March 2026, centre on allegations that Shetty and associates orchestrated systematic fraud over multiple years, inflating assets and understating liabilities through undisclosed related-party transactions to obscure the group's true financial position. The $5.4 billion figure represents the alleged quantum of the fraud.

Administrators from Alvarez & Marsal, appointed in 2020, spent three years unwinding NMC's positions and recovering assets. Parts of the business were sold to UAE buyers; other facilities were absorbed by competitors or closed. Both DOH and DHA supervised the transition of patient services throughout the restructuring period.

• Administration date: April 2020
• Debt disclosed to shareholders at collapse: $2.1 billion
• Total hidden debt uncovered: over $6.6 billion
• UAE facilities at peak: 200+
• Alleged fraud quantum in current trial: $5.4 billion

Governance implications for Gulf healthcare operators

The NMC collapse set new terms for how private healthcare deals get financed in the Gulf. Since 2020, requirements around related-party loan disclosure, off-balance-sheet facilities, auditor independence, and board oversight have become standard expectations in UAE healthcare capital market transactions, a shift that post-administration reviews of NMC directly accelerated.

Abu Dhabi's sector has grown since the collapse. The DOH's 2030 health strategy has attracted new hospital groups and tech-enabled clinic networks, many structured as joint ventures with Abu Dhabi sovereign entities.

A conviction, and any associated civil recovery action, will likely accelerate scrutiny of audit and board oversight standards across the region's listed health companies. For boards with capital market transactions planned in Abu Dhabi or Dubai, the trial proceedings are worth tracking closely.